Kamili, Alvin
Gifford, Andrew J.
Li, Nancy
Mayoh, Chelsea
Chow, Shu-Oi
Failes, Timothy W.
Eden, Georgina L.
Cadiz, Roxanne
Xie, Jinhan
Lukeis, Robyn E.
Norris, Murray D.
Haber, Michelle
McCowage, Geoffrey B.
Arndt, Greg M.
Trahair, Toby N. http://orcid.org/0000-0002-3295-228X
Fletcher, Jamie I. http://orcid.org/0000-0003-2949-9469
Funding for this research was provided by:
Neuroblastoma Australia Kid's Cancer Alliance
Article History
Received: 27 June 2019
Revised: 18 September 2019
Accepted: 20 September 2019
First Online: 10 January 2020
Ethics approval and consent to participate
: All tumour specimens were obtained from patients at the Sydney Children’s Hospital Network (SCHN) under approval by the SCHN Human Research Ethics Committee (LNR/14/SCHN/392, LNR/14/SCHN/497). Informed parental or guardian consent was obtained for each patient. The study was performed in accordance with the Declaration of Helsinki.
: All samples used in this study were de-identified. No personal information was exposed.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: The authors declare no competing interests.
: This study was supported by the Kids Cancer Alliance, a Cancer Institute New South Wales Translational Cancer Research Centre (J.I.F., T.N.T.) and by Neuroblastoma Australia (J.I.F., T.N.T.).